Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021

SELL
$4.57 - $11.18 $45,700 - $111,800
-10,000 Closed
0 $0
Q4 2020

Jan 22, 2021

BUY
$3.73 - $5.6 $37,300 - $56,000
10,000 New
10,000 $45,000
Q3 2020

Oct 26, 2020

SELL
$4.32 - $11.7 $56,160 - $152,100
-13,000 Closed
0 $0
Q2 2020

Jul 16, 2020

BUY
$2.94 - $9.1 $38,220 - $118,300
13,000 New
13,000 $115,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.42B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Perennial Investment Advisors, LLC Portfolio

Follow Perennial Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Investment Advisors, LLC with notifications on news.